Clinical guideline for neurorestorative therapy in pediatric cerebral palsy (2024 China version)
Journal of Neurorestoratology · 2025-12 · 13 (6) · 100253
DOI: 10.1016/j.jnrt.2025.100253 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Neurorestoratology, 2025-12. Verfasst von Zhonghai Li und 19 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Dalian Science and Technology Innovation Fund.
Abstract (Originalsprache)
Cerebral palsy (CP) is a common pediatric neuromotor disorder that is characterized by persistent impairments in movement, muscle tone, and posture. It is frequently associated with sensory, cognitive, and behavioral comorbidities. This guideline presents evidence-based recommendations for neurorestorative therapy in pediatric CP, developed through a systematic review of 44 studies (including randomized controlled trials, cohort studies, and systematic reviews) published up to December 31, 2024. Recommendations were graded according to the Oxford Centre for Evidence-Based Medicine Levels of Evidence. Key recommendations include the use of the Gross Motor Function Classification System for precise motor dysfunction grading, neuroimaging-supported diagnostic criteria, and a multidisciplinary neurorestorative treatment approach. This approach encompasses cell therapy (Grade B) , pharmacological management (Grades B–C) , surgical interventions (Grade B) , neuromodulation (Grade B) , structured rehabilitation (Grade B) , and psychological support (Grade C) . The guideline also advocates for a multi-tiered prevention strategy targeting primary, secondary, and tertiary levels. By emphasizing evidence-based, individualized, and multidisciplinary care, this guideline aims to optimize neurorestorative outcomes and improve quality of life for children with CP, while encouraging ongoing research and periodic updates as new evidence emerges.
Förderung
- National Key Research and Development Program of China
- Dalian Science and Technology Innovation Fund
Zitieren
APA
Li, Z., So, K., Chen, L., Feng, S., Hu, Y., Cheng, L., Hou, X., Li, D., Huang, W., Qiu, J., Cheng, G., Wang, J., Li, T., Liu, W., Han, C., Guan, X., Wang, Y., Du, L., Huang, H., & Liu, J. (2025). Clinical guideline for neurorestorative therapy in pediatric cerebral palsy (2024 China version). Journal of Neurorestoratology, 13(6), 100253. https://doi.org/10.1016/j.jnrt.2025.100253
Vancouver
Li Z, So K, Chen L, Feng S, Hu Y, Cheng L, et al. Clinical guideline for neurorestorative therapy in pediatric cerebral palsy (2024 China version). Journal of Neurorestoratology. 2025;13(6):100253. doi:10.1016/j.jnrt.2025.100253
BibTeX
@article{Li2025,
author = {Li, Zhonghai and So, Kwok-Fai and Chen, Lin and Feng, Shiqing and Hu, Yong and Cheng, Liming and Hou, Xinlin and Li, Dong and Huang, Weimin and Qiu, Jiujun and Cheng, Guoqiang and Wang, Jun and Li, Tonghuan and Liu, Weipeng and Han, Chao and Guan, Xin and Wang, Yachen and Du, Lili and Huang, Hongyun and Liu, Jing},
title = {Clinical guideline for neurorestorative therapy in pediatric cerebral palsy (2024 China version)},
journal = {Journal of Neurorestoratology},
year = {2025},
volume = {13},
number = {6},
pages = {100253},
doi = {10.1016/j.jnrt.2025.100253}
}
EUVIMED